SE0001631D0 - New use - Google Patents

New use

Info

Publication number
SE0001631D0
SE0001631D0 SE0001631A SE0001631A SE0001631D0 SE 0001631 D0 SE0001631 D0 SE 0001631D0 SE 0001631 A SE0001631 A SE 0001631A SE 0001631 A SE0001631 A SE 0001631A SE 0001631 D0 SE0001631 D0 SE 0001631D0
Authority
SE
Sweden
Prior art keywords
new use
fucoidin
arthritis
mammals
manufacture
Prior art date
Application number
SE0001631A
Other languages
English (en)
Inventor
Andrej Tarkowski
Margareta Verdengh
Original Assignee
Sahltech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sahltech Ab filed Critical Sahltech Ab
Priority to SE0001631A priority Critical patent/SE0001631D0/sv
Publication of SE0001631D0 publication Critical patent/SE0001631D0/sv
Priority to PCT/SE2001/000962 priority patent/WO2001082936A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
SE0001631A 2000-05-04 2000-05-04 New use SE0001631D0 (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0001631A SE0001631D0 (sv) 2000-05-04 2000-05-04 New use
PCT/SE2001/000962 WO2001082936A1 (en) 2000-05-04 2001-05-04 Use of fucoidin in the treatment of arthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0001631A SE0001631D0 (sv) 2000-05-04 2000-05-04 New use

Publications (1)

Publication Number Publication Date
SE0001631D0 true SE0001631D0 (sv) 2000-05-04

Family

ID=20279536

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0001631A SE0001631D0 (sv) 2000-05-04 2000-05-04 New use

Country Status (2)

Country Link
SE (1) SE0001631D0 (sv)
WO (1) WO2001082936A1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6812220B2 (en) * 2001-08-29 2004-11-02 University Of British Columbia Pharmaceutical compositions and methods relating to fucans
FR2881051A1 (fr) * 2005-01-27 2006-07-28 Therapol Sa Utilisation de fucanes selectionnes pour la preparation d'un materiau bacteriophobe et bacteriostatique, materiau correspondant et applications
IL172477A (en) 2005-12-08 2012-06-28 Univ Ben Gurion Addition of viscosity by algae polysaccharides to treat arthritis
WO2010109736A1 (ja) * 2009-03-25 2010-09-30 国立大学法人鳥取大学 軟骨生成促進剤および軟骨損傷由来疾病の予防治療剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1255695A (en) * 1993-11-19 1995-06-06 Regents Of The University Of California, The Sulfated ligands for l-selectin and methods of preventing sulfate addition
US5783693A (en) * 1993-11-19 1998-07-21 The Regents Of The University Of California Methods for synthesizing sulfated disaccharide inhibitors of selectins
US5980865A (en) * 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases

Also Published As

Publication number Publication date
WO2001082936A1 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
MXPA03011546A (es) Formulacion farmaceutica.
AU3652102A (en) Compounds and their uses
SE0102315D0 (sv) Compounds
SE0101675D0 (sv) Novel composition
BRPI0418251A (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos para o tratamento de doenças virais
PT1309589E (pt) Compostos de ureia e metodos de utilizacao
ATE263157T1 (de) Nematizide trifluorbutene
SE0301653D0 (sv) Novel compounds
ATE448232T1 (de) Substituierte heterozyklen
GB0111186D0 (en) Novel compounds
MXPA02012042A (es) Compuestos efectivos como agonistas de beta-2-adrenorreceptor, y como inhibidores de pde4.
BR0306922A (pt) N-pirazinil-fenilsulfonamidas e seu uso no tratamento de doenças mediadas por quimocina
ATE330017T1 (de) Kallikrein gen
DK1315506T3 (da) Phospholipidderivater af valproinsyre og blandinger deraf
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
SE9901077D0 (sv) Novel use
SE9801494D0 (sv) Novel use
SE0003476D0 (sv) Compounds
ATE335739T1 (de) Cak inhibitoren und deren verwendungen
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
DK1438034T3 (da) Anvendelse af -phenyl-3-dimethylaminiopropanforbindelser til behandling af urininkontinens
SE0300457D0 (sv) Novel compounds
SE0001631D0 (sv) New use
BR0111785A (pt) Composições e métodos para tratamento de candidìase
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.